Duke: Trent Ctr., Humanities in Med : J. Karlawish: How Risk is Remaking Med

Dr. Jason Karlawish, Prof. of Medicine, Medical Ethics & Health Policy at the Perelman School of Medicine, Univ. of Pennsylvania will present: "From the Bedside to the Desktop: How Risk is Remaking Medicine." Lunch will be provided at noon, talk begins @ 12:10pm

When May 08, 2013
from 12:00 PM to 01:00 PM
Where Duke Hospital Lecture Hall 2003 - one floor directly above main lobby
Contact Name
Contact Phone 919.668.9000
Add event to calendar vCal
iCal

For much of the modern era, medicine worked at the bedside. "Go to the bedside" was a senior physician's command to trainees, a command indicating where to discover, diagnose, and treat disease. The patient's chief complaint and the detailed history and physical that followed were the foundation of the medical encounter and medical knowledge. But today medicine occupies a new space. Physicians discover diseases and diagnose and treat patients at the "desktop." Desktop medicine describes how risk assessment and information technologies are transforming medicine. The desktop with a networked computer--and that computer with its own virtual desktop--are where researchers examine and discover risks and where clinicians and patients meet to assess a patient's risk factors and decide whether the patient needs treatment. This talk will consider this new model of medicine and its broad implications for medical training, the doctor-patient relationship, and the practice of medicine.

Jason Karlawish, MD is Professor of Medicine, Medical Ethics and Health Policy at the University of Pennsylvania. He is the director of Penn's Neurodegenerative Disease Ethics and Policy Program and the director of the Alzheimer's Disease Center's Education, Recruitment and Retention Core. His clinical practice centers on the diagnosis and treatment of persons with Alzheimer's disease and related disorders. Professor Karlawish's research focuses on neuroethics, particularly on research and care of older adults and persons with late-life cognitive disorders such as Alzheimer's disease and Parkinson's disease. His has investigated issues in dementia drug development, informed consent, quality of life, research and treatment decision making, biomarkers, and voting by persons with cognitive impairment and residents of long-term care facilities. He currently serves on the Board of Directors of The Greenwall Foundation and the American Bar Association's Commission on Law and Aging, and is the associate editor for ethics, policy and economics for the Journal of the American Geriatrics Society.